Summary
Cimetidine is an H2 antagonist which inhibits cytochrome P-450 and reduces hepatic blood flow. To determine whether cimetidine interferes with the plasma pharmacokinetics of doxorubicin, we gave six female New Zealand rabbits doxorubicin 3 mg/kg, followed a month later by cimetidine 120 mg/kg every 12 h over 72 h and doxorubicin 3 mg/kg. Serial plasma specimens were obtained over 72 h and assayed for doxorubicin and its metabolites by high-performance liquid chromatography and fluorescence detection.
Doxorubicin plasma pharmacokinetics were prolonged after cimetidine pretreatment [AUC 0.76±0.22 vs. 2.85±1.22 μM×h, no pretreatment vs pretreatment (p=0.005), half-life=11.7±6.55 vs 28.0±8.16 h (P=0.0002), and clearance=0.129±0.036 vs 0.036±0.0111/min-1 kg-1 (P=0.0007)]. No significant differences were found between the AUCs for doxorubicinol, 7-deoxy doxorubicinol aglycone, or two unidentified nonpolar metabolites in nonpretreatment and pretreatment studies. Cimetidine increases and prolongs the plasma exposure to doxorubicin in rabbits. Doxorubicin metabolism does not appear to be affected by cimetidine.
Similar content being viewed by others
References
Algozzine GJ, Stewart RB, Springer PK (1981) Decreased clearance of phenytoin with cimetidine. Ann Intern Med 95: 244–245
Andrews PA, Brenner DE, Chou FTE, Kubo H, Bachur NR (1980) Facile and definitive determination of human adriamycin and daunorubicin metabolites by high-pressure liquid chromatography. Drug Metab Dispos 8: 152–156
Bachur NR (1979) Anthracycline antibiotic pharmacology and metabolish. Cancer Treat Rep 63: 817–820
Benet LZ, Babeazzi RL (1979) Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 68: 1071–1074
Benjamin RS, Riggs CE, Bachur NR (1977) Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res 37: 1416–1420
Brenner DE, Grosh WW, Noone R, Stein R, Greco FA, Hande KR (1984a) Human plasma pharmacokinetics of doxorubicin Comparison of bolus and infusional administration. Cancer Treat Symp 3: 77–83
Brenner DE, Noone R, Hande KR (1984b) A comparison of doxorubicin pharmacokinetics in the rabbit and in man. Proc Am Assoc Cancer Res 28: 300
Brenner DE, Galloway S, Cooper J, Noone R, Hande KR (1985) Improved high-performance liquid chromatography assay of doxorubicin Detection of circulating aglycones in human plasma and comparison with thin-layer chromatography. Cancer Chemother Pharmacol 14: 139–145
Chang P, Riggs CE, Scheerer BA, Wiernik PH, Bachur NR (1976) Combination chemotherapy with adriamycin and streptozotocin. Clin Pharmacol Ther 20: 611–616
Desmond PV, Patwardhan RN, Schenker S, Speeg KV (1980) Cimetidine impairs the elimination of chlordiazepoxide (Librium) in man. Ann Intern Med 93: 266–268
Dodion P, Riggs CF, Akman SR, Tamburini JM, Colvin OM, Bachur NR (1984) Interactions between cyclophosphamide and adriamycin metabolism in rats. J Pharmacol Exp Ther 229: 51–57
Evans WE, Crom WR, Yee G, Green AA, Hayes FA, Pratt CB, Avery TL (1980) Adriamycin pharmacokinetics in children. Proc ASCO AACR 21: 176
Fairfax AJ, Adam J, Pagan FS (1978) Effect of cimetidine on the absorption of oral benzylpenicillin. Br Med J I: 820
Felsted RL, Bachur NR (1980) Mammalian carbonyl reductase. Drug Metab Rev 11: 1–60
Freely J, Wilkinson GR, McAllister CB, Wood AJJ (1980) Increased toxicity and reduced clearance of lidocaine by cimetidine. Ann Intern Med 96: 592–594
Garnick MB, Ensminger WD, Israel M (1979) A clinical pharmacological evaluation of hepatic arterial infusion of adriamycin. Cancer Res 39: 4105–4110
Greene RF, Collins JM, Jenkins JF, Speyer JL, Myers CE (1983) Plasma pharmacolinetics of adriamycin and adriamycinol Implication for the design of in vitro experiments and treatment protocols. Cancer Res 43: 3417–3421
Hande KR, Noone RM (1983) Cimetidine prolongs the half-life of procarbazine and hexamethylmelamine. Proc Am Assoc Cancer Res 24: 287
Harvey VJ, Slevin ML, Dilloway MR, et al (1984) The influence of cimetidine on the pharmacokientics of 5-fluorouracil. Br J Clin Pharmacol 18: 421–430
Kirch W, Kohler H, Spahn H, Mutschler E (1981) Interaction of cimetidine with metoprolol, propranolol, or atenolol. Lancet 2: 531–532
Klotz U, Reimann I (1980) Influence of cimetidine on the pharmacokinetics of desmethyldiazepam and oxazepam. Eur J Clin Pharmacol 18: 517–520
Klotz GD (1979) MLAB — A mathematical modeling tool. Comput Programs Biomed 10: 271–280
McKinney TD Myers P, Speeg KV Jr (1981) Renal organic base transport Cimetidine secretion by proximal straight tubules. Clin Res 29471A
Pelkonen O, Puurunen J (1980) The effect of cimetidine on in vitro and in vivo microsomal drug metabolism in the rat. Biochem Pharm 29: 3075–3080
Puurunen J, Sotaniemi E, Pelkonen O (1980) Effect of cimetidine on microsomal drug metabolism in man. Eur J Clin Pharmacol 18: 185–187
Reich SD, Bachur NR (1976) Alterations in adriamycin efficacy by phenobarbital. Cancer Res 36: 3803–3806
Reimann IW, Klotz U, Siems B, Frolich JC (1981) Cimetidine increases steady state plasma levels of propranolol. Br J Clin Pharmacol 12: 785–790
Roberts RK, Grice J, Wood L, Petroff V, McGuffie C (1981) Cimetidine impairs the elimination of theophylline and antipyrine. Gastroenterology 81: 19–21
Ruffalo RL, Thompson JF, Segal JL (1981) Diazepam-benzodiazepine drug interaction. Am J Hosp Pharm 38: 1365–1366
Silver BA, Bell WR (1979) Cimetidine protentiation of the hypoprothominemic effect of warfarin. Ann Intern Med 90: 348–349
Takanashi S, Bachur NR (1976) Adriamycin metabolism in man Evidence from urinary metabolites. Drug Metab Dispos 4: 79–97
Van der Meer JWM, Keuning JJ, Scheijgrond HW, Heykants J, Van Cutsem J, Brugmans J (1980) The influence of gastric acidity on the bioavailability of ketoconazole. J Antimicrob Chemother 6: 552–554
Author information
Authors and Affiliations
Additional information
Grant Support Veterans Administration, NIH Grant RR-05424 and Clinical Research Center Grant RR-00095 American Cancer Society Institutional Grants #IN25V and IN24V, and JFCF #649
Rights and permissions
About this article
Cite this article
Brenner, D.E., Collins, J.C. & Hande, K.R. The effects of cimetidine upon the plasma pharmacokinetics of doxorubicin in rabbits. Cancer Chemother. Pharmacol. 18, 219–222 (1986). https://doi.org/10.1007/BF00273389
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00273389